Company page

Genmab A/s

Genmab A/S is a public company listed on the Danish stock market under the ticker GMAB. The company has a market capitalization of approximately 17.26 billion USD. Genmab focuses on developing innovative antibody therapies for the treatment of cancer and other diseases.

GMAB:OMXCOPUpdated September 12, 2026
Genmab A/s logo
Ticker
GMAB:OMXCOP
Asset type
Stock
Market cap
$19.28B
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXCOP
Currency
DKK